ADPT

ADAPTIVE BIOTECHNOLOGIES

Data as of 2026 Q2 (06-30) · 13F snapshot

Summary

ADAPTIVE BIOTECHNOLOGIES (ADPT) is held as common stock by 8 tracked hedge-fund managers, with a combined reported value of ~$723.54M; the largest are Andreas Halvorsen, Cathie Wood, Paul Tudor Jones. 1 tracked manager also disclosed PUT or CALL positions, reported separately below. This quarter: 1 added, 5 trimmed, 1 closed. Data as of 2026 Q2, from public SEC 13F filings, delayed up to ~45 days.

Attention · HighThis quarter · Cooling

Common-stock holders81 also report options

Congress trades0

Price$28.51vs quarter-end+32.91%

Sectors0

This quarter's moves

New0

Added1

Trimmed / sold6

Top holder

Andreas Halvorsen

Common-stock positions

PUT and CALL disclosures are excluded from these holder counts and values.

Andreas HalvorsenHold

Value $643.37M1.8% of portfolio29,993,7082026 Q2

Cathie WoodHold

Value $44.84M0.3% of portfolio2,090,3062026 Q2

Investor	Period	Value	Shares	% of portfolio	Action
Andreas Halvorsen	2026 Q2	$643.37M	29,993,708	1.8%	Hold
Cathie Wood	2026 Q2	$44.84M	2,090,306	0.3%	Hold

PUT / CALL disclosures

Reported separately: 13F option values are not common-stock ownership and do not reveal the full strategy or economic exposure.

Ken GriffinCALL—

Value $1.65M— of portfolio77,0002026 Q2

Investor	Period	Value	Shares	% of portfolio	Action
Ken GriffinCALL	2026 Q2	$1.65M	77,000	—	—

Insider Trading

Officers · directors · Form 4

Open-market purchases and sales (P/S)15

Francis Lo
Chief People Officer
Sell$3.01M
107,537 @ $28.02Traded 2026-09-16Filed 2026-09-18
Francis Lo
Chief People Officer
Sell$224.8K
7,869 @ $28.57Traded 2026-09-16Filed 2026-09-18
Susan Bobulsky
Chief Commercial Officer, MRD
Sell$32.3K
1,195 @ $27.00Traded 2026-09-15Filed 2026-09-17
Katey Einterz Owen
Director
Sell$250.0K
9,615 @ $26.00Traded 2026-08-26Filed 2026-08-28
Robert Hershberg
Director
Sell$365.9K
15,000 @ $24.39Traded 2026-08-18Filed 2026-08-20
Robert Hershberg
Director
Sell$382.4K
15,664 @ $24.41Traded 2026-08-18Filed 2026-08-20
Chad M Robins
CEO and Chairman
Sell$6.82M
278,472 @ $24.48Traded 2026-08-17Filed 2026-08-19
Chad M Robins
CEO and Chairman
Sell$5.1K
204 @ $25.14Traded 2026-08-17Filed 2026-08-19
Chad M Robins
CEO and Chairman
Sell$8.00M
318,799 @ $25.08Traded 2026-08-17Filed 2026-08-19
Peter M Neupert
Director
Sell$1.75M
69,690 @ $25.16Traded 2026-08-17Filed 2026-08-19
Peter M Neupert
Director
Sell$1.00M
40,000 @ $25.10Traded 2026-08-17Filed 2026-08-19
Peter M Neupert
Director
Sell$378.4K
15,000 @ $25.23Traded 2026-08-17Filed 2026-08-19
Chad M Robins
CEO and Chairman
Sell$64.6K
2,525 @ $25.57Traded 2026-08-17Filed 2026-08-19
Susan Bobulsky
Chief Commercial Officer, MRD
Sell$75.0K
3,000 @ $25.00Traded 2026-08-10Filed 2026-08-12
Susan Bobulsky
Chief Commercial Officer, MRD
Sell$31.2K
1,299 @ $24.00Traded 2026-07-30Filed 2026-08-03

Insider transactions are public SEC Form 4 disclosures (company officers, directors, 10% owners), for research only — not investment advice.

ARK ETF holdings

Cathie Wood · daily

ARK total shares held · drag to inspect

2026-09-29holds 1,794,547

ARKGweight in fund2.35%$51.16M

ARK publishes full ETF holdings daily (SEC Rule 6c-11). Line shows ARK's total shares held over time (not price); markers are buy/sell days. Derived from public CSVs — research only, not investment advice.

Public SEC 13F filings may appear up to 45 days after quarter-end; STOCK Act / OGE trade filings are generally due within 45 days but may be late. Partial data only — research, not investment advice.